Kiniksa Pharmaceuticals International (KNSA) Operating Income (2017 - 2026)
Kiniksa Pharmaceuticals International's Operating Income was $27.19 million in Q2 2026, up 34.9% from $20.16 million a year earlier but down 7.1% from the prior quarter.
Powered by 
Analysis
Kiniksa Pharmaceuticals International (KNSA) Operating Income (2017 - 2026) Analysis & Trends
On a trailing twelve-month basis, Kiniksa Pharmaceuticals International's Operating Income was $100.25 million through Jun 30, 2026; for FY2025, it was $77.22 million.
- In earlier years, Operating Income was -$45.62 million in FY2024, -$25.2 million in FY2023, $9.77 million in FY2022 and -$156.64 million in FY2021.
- Quarterly Operating Income has moved between -$36.13 million (Q4 2021) and $46.41 million (Q3 2022) over five years.
- Per Business Quant data, KNSA's Operating Income in the three quarters before Q2 2026 was $29.27 million (Q1 2026), $19.77 million (Q4 2025) and $24.02 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 3.16 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 3.51 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -10.39 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 4.27 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Kiniksa Pharmaceuticals International | 11.81 Bn | 10.55 Bn | 220.03 Mn | 27.19 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 27.19 Mn |
| Mar 31, 2026 | 29.27 Mn |
| Dec 31, 2025 | 19.77 Mn |
| Sep 30, 2025 | 24.02 Mn |
| Jun 30, 2025 | 20.16 Mn |
| Mar 31, 2025 | 13.27 Mn |
| Dec 31, 2024 | -19.30 Mn |
| Sep 30, 2024 | -9.66 Mn |
| Jun 30, 2024 | -117,000.00 |
| Mar 31, 2024 | -16.54 Mn |
| Dec 31, 2023 | 81,000.00 |
| Sep 30, 2023 | -10.93 Mn |
| Jun 30, 2023 | -3.15 Mn |
| Mar 31, 2023 | -11.20 Mn |
| Dec 31, 2022 | 6.05 Mn |
| Sep 30, 2022 | 46.41 Mn |
| Jun 30, 2022 | -19.37 Mn |
| Mar 31, 2022 | -23.32 Mn |
| Dec 31, 2021 | -36.13 Mn |
| Sep 30, 2021 | -30.67 Mn |
API Access
Kiniksa Pharmaceuticals International Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-income&ticker=KNSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-income", "ticker": "KNSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-income&ticker=KNSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();